Constellation Pharmaceuticals

YTD

ALL

Why Robinhood?

You can watch CNST and buy or sell other stocks, ETFs, and their options commission-free!

About CNST

Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity.

CEO

Jigar Raythatha, MBA

CEOJigar Raythatha, MBA

Employees

—

Employees—

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2008

Founded2008

Employees

—

Employees—

CNST Key Statistics

Market cap

1.63B

Market cap1.63B

Price-Earnings ratio

-11.21

Price-Earnings ratio-11.21

Dividend yield

—

Dividend yield—

Average volume

657.81K

Average volume657.81K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$39.30

52 Week high$39.30

52 Week low

$17.00

52 Week low$17.00

People also own

Based on the portfolios of people who own CNST. This list is generated using Robinhood data, and it’s not a recommendation.